Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Seneschal

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The British Journal of Dermatology|June 15, 2021
Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohortM Beylot-Barry, J Seneschal, D Tran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2019
Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter studyM Jachiet, A Nosbaum, D Staumont-Sallé, et al.
Journal Francais D'Ophtalmologie|January 26, 2022
[Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?]S Doan, L Arnould, C Febvay, et al.
The British Journal of Dermatology|September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013E Sbidian, C Hotz, J Seneschal, et al.
The British Journal of Dermatology|October 9, 2012
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trialS Prey, K Ezzedine, A Doussau, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2025
Real-life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre studyA Mourtada, C Douarec, M Wargny, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 18, 2020
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and childrenA Wollenberg, S Christen-Zäch, A Taieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2019
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation periodC Vestergaard, A Wollenberg, S Barbarot, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The British Journal of Dermatology|June 15, 2021
Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohortM Beylot-Barry, J Seneschal, D Tran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2019
Low cardiovascular risk and poor quality of life associated with tobacco use and skin infections in adult atopic dermatitis: result of a French multicenter studyM Jachiet, A Nosbaum, D Staumont-Sallé, et al.
Journal Francais D'Ophtalmologie|January 26, 2022
[Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?]S Doan, L Arnould, C Febvay, et al.
The British Journal of Dermatology|September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013E Sbidian, C Hotz, J Seneschal, et al.
The British Journal of Dermatology|October 9, 2012
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trialS Prey, K Ezzedine, A Doussau, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2025
Real-life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre studyA Mourtada, C Douarec, M Wargny, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 18, 2020
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and childrenA Wollenberg, S Christen-Zäch, A Taieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2019
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation periodC Vestergaard, A Wollenberg, S Barbarot, et al.
Pageof 7